DRI-C21045
DRI-C21045 (compound 10) is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC50 of 0.17 μM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC50s of 17.1 μM and 4.5 μM, respectively[1].
Product Specifications
CAS Number
2101765-81-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dri-c21045.html
Purity
98.11
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=CC2=CC=CC(NC(C3=CC=C(C4=CC=C(NC(C5=CC=C(C(OC)=O)C=C5)=O)C=C4)C=C3)=O)=C21)(O)=O
Molecular Formula
C32H24N2O7S
Molecular Weight
580.61
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HLA-DQA1 (HLA-DQA1, CD, CELIAC1, DQ-A1, GSE, HLA-DQA, DQ alpha 1 chain, DC-1 alpha chain, DC-alpha, HLA-DCA, MHC class II DQA1) (Biotin)
HLA-DQA1 (HLA-DQA1, CD, CELIAC1, DQ-A1, GSE, HLA-DQA, DQ alpha 1 chain, DC-1 alpha chain, DC-alpha, HLA-DCA, MHC class II DQA1) (Biotin)
Monoclonal FN1 / Fibronectin Antibody (clone 23C9), Clone: 23C9
